These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 18996742

  • 21. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL.
    Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
    [Abstract] [Full Text] [Related]

  • 22. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
    Weinling E, McDougall S, Andre F, Bianchetti G, Dubruc C.
    Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
    [Abstract] [Full Text] [Related]

  • 24. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N, Nakajima T, Hayash K, Nose I, Hashizume Y, Ohyama T, Habukawa M, Kotorii N, Kuwahara H, Maeda H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [Abstract] [Full Text] [Related]

  • 25. Effect of zolpidem on sleep in healthy subjects: a placebo-controlled trial with polysomnographic recordings.
    Blois R, Gaillard JM, Attali P, Coquelin JP.
    Clin Ther; 1993 Jan; 15(5):797-809. PubMed ID: 8269446
    [Abstract] [Full Text] [Related]

  • 26. Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia.
    Erman MK, Loewy DB, Scharf MB.
    Curr Med Res Opin; 2005 Feb; 21(2):223-30. PubMed ID: 15801993
    [Abstract] [Full Text] [Related]

  • 27. Acute effects of zolpidem on daytime alertness, psychomotor and physical performance.
    Ito SU, Kanbayashi T, Takemura T, Kondo H, Inomata S, Szilagyi G, Shimizu T, Nishino S.
    Neurosci Res; 2007 Nov; 59(3):309-13. PubMed ID: 17825448
    [Abstract] [Full Text] [Related]

  • 28. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC, van Balkom AJ, Zitman FG.
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):301-6. PubMed ID: 15163440
    [Abstract] [Full Text] [Related]

  • 29. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
    Uchimura N, Kamijo A, Kuwahara H, Uchiyama M, Shimizu T, Chiba S, Inoue Y.
    Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
    [Abstract] [Full Text] [Related]

  • 30. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J.
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Sublingual zolpidem (Edluar™; Sublinox™).
    Yang LP, Deeks ED.
    CNS Drugs; 2012 Nov; 26(11):1003-10. PubMed ID: 23034583
    [Abstract] [Full Text] [Related]

  • 33. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL.
    Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
    [Abstract] [Full Text] [Related]

  • 34. The dose effects of zolpidem on the sleep of healthy normals.
    Merlotti L, Roehrs T, Koshorek G, Zorick F, Lamphere J, Roth T.
    J Clin Psychopharmacol; 1989 Feb; 9(1):9-14. PubMed ID: 2651493
    [Abstract] [Full Text] [Related]

  • 35. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
    Paterson LM, Nutt DJ, Ivarsson M, Hutson PH, Wilson SJ.
    J Psychopharmacol; 2009 Jul; 23(5):487-94. PubMed ID: 19351801
    [Abstract] [Full Text] [Related]

  • 36. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M, Mizuki Y, Yamamoto K, Uchida S, Watanabe Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):839-47. PubMed ID: 17328999
    [Abstract] [Full Text] [Related]

  • 37. Comparison of actigraphy and polysomnography to assess effects of zolpidem in a clinical research unit.
    Peterson BT, Chiao P, Pickering E, Freeman J, Zammit GK, Ding Y, Badura LL.
    Sleep Med; 2012 Apr 09; 13(4):419-24. PubMed ID: 22317945
    [Abstract] [Full Text] [Related]

  • 38. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting.
    Hajak G, Bandelow B, Zulley J, Pittrow D.
    Ann Clin Psychiatry; 2002 Mar 09; 14(1):1-7. PubMed ID: 12046635
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery.
    Morgan PJ, Chapados R, Chung FF, Gauthier M, Knox JW, Le Lorier J.
    J Clin Anesth; 1997 Mar 09; 9(2):97-102. PubMed ID: 9075032
    [Abstract] [Full Text] [Related]

  • 40. Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.
    Greenblatt DJ, Harmatz JS, Roth T, Singh NN, Moline ML, Harris SC, Kapil RP.
    Clin Ther; 2013 May 09; 35(5):604-11. PubMed ID: 23541711
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.